Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.